Cyclacel Pharmaceuticals Inc. | Key People and Executives
Spiro Rombotis
President, Chief Executive Officer & Director
Paul McBarron
COO, CFO, Secretary, Director & Executive VP
Robert Jay Spiegel
Director
David C. U'Prichard
Chairman
Christopher S. Henney
Vice Chairman
Samuel L. Barker
Independent Director
Lloyd M. Sems
Independent Director
Gregory T. Hradsky
Independent Director
John Michael Middlecott Banham
Independent Director
Spiro Rombotis
President, Chief Executive Officer & Director
Paul McBarron
COO, CFO, Secretary, Director & Executive VP
David Glover
Chief Scientist
Susan Davis
Senior Director-Business Development
Robert Jay Spiegel
Director
Judy Chiao
VP-Clinical Development & Regulatory Affairs
David C. U'Prichard
Chairman
Christopher S. Henney
Vice Chairman
Samuel L. Barker
Independent Director
Lloyd M. Sems
Independent Director
Gregory T. Hradsky
Independent Director
John Michael Middlecott Banham
Independent Director
| Address |
200 Connell Drive
Berkeley Heights New Jersey 07922
United States
|
|
Employees
|
- |
| Website |
http://www.cyclacel.com |
| Updated |
07/08/2019 |
| Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop innovative, targeted medicines for cancer and other proliferative diseases. The company builds a diversified biopharmaceutical business, which is focused in hematology and oncology based on a pipeline of novel drug candidates. |
